Engineers Gate Manager’s Rigel Pharmaceuticals RIGL Stock Holding History

Engineers Gate Manager’s Portfolio RIGL Stock Details RIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$934K	Sell	23,866 -4,422	-16%	-$136K	0.01%	1132
2026 Q1	$765K	Buy	28,288 +10,056	+55%	+$338K	0.01%	1183
2025 Q4	$781K	Sell	18,232 -7,833	-30%	-$295K	0.01%	1157
2025 Q3	$738K	Buy	+26,065	New	+$780K	0.01%	1320
2025 Q1	–	Sell	-12,609	Closed	-$212K	–	2504
2024 Q4	$212K	Buy	+12,609	New	+$242K	﹤0.01%	1866
2024 Q2	–	Sell	-1,016	Closed	-$15K	–	2181
2024 Q1	$15K	Hold	1,016	–	–	﹤0.01%	1847
2023 Q4	$14.7K	Hold	1,016	–	–	﹤0.01%	1920
2023 Q3	$11K	Sell	1,016 -10	-1%	-$120	﹤0.01%	1725
2023 Q2	$13.2K	Hold	1,026	–	–	﹤0.01%	1677
2023 Q1	$13.5K	Buy	1,026 +10	+1%	+$159	﹤0.01%	1595
2022 Q4	$15.2K	Buy	+1,016	New	+$9.31K	﹤0.01%	1616
2022 Q2	–	Sell	-3,452	Closed	-$103K	–	2205
2022 Q1	$103K	Buy	+3,452	New	+$93.5K	﹤0.01%	1705
2017 Q4	–	Sell	-3,143	Closed	-$80K	–	837
2017 Q3	$80K	Sell	3,143 -3,922	-56%	-$95.4K	0.01%	668
2017 Q2	$193K	Buy	+7,065	New	+$193K	0.02%	598

Other funds holding RIGL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Engineers Gate Manager's RIGL Position: Q2 2026 in Review

Engineers Gate Manager reduced its Rigel Pharmaceuticals (RIGL) stake by 16% in Q2 2026, selling an estimated $136K and leaving 23,866 shares worth $934K. The position accounts for 0.01% of the portfolio, ranked #1132.

Engineers Gate Manager first reported a position in RIGL in Q2 2017 and has held it in 14 quarters since. 156 funds tracked by Wall St. Rank hold RIGL as of Q2 2026.

Engineers Gate Manager held 23,866 shares of Rigel Pharmaceuticals worth $934K as of Q2 2026.
Engineers Gate Manager sold 4,422 Rigel Pharmaceuticals shares in Q2 2026, an estimated $136K.
Rigel Pharmaceuticals made up 0.01% of Engineers Gate Manager's portfolio in Q2 2026, its #1132 holding.
Engineers Gate Manager first reported a position in Rigel Pharmaceuticals in Q2 2017 and has held it in 14 quarters since.
156 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.